Bragar Eagel & Squire, P.C. Is Investigating Dave, Red Cat, Perpetua, and Voyager and Encourages Investors to Contact the Firm
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
3,034€
3,13%
Echtzeit-Aktienkurs Voyager Therapeutics
Bid:
Ask:
Nachrichten zur Voyager Therapeutics Aktie
Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call Transcript
…
Voyager Therapeutics stock tumbles after IND application delayed By Investing.com
Voyager Therapeutics stock tumbles after IND application delayed…
Voyager Therapeutics Aktie: Attraktive Einstiegsmöglichkeit
Los Angeles (www.aktiencheck.de) - Voyager Therapeutics-Aktienanalyse von Wedbush Securities:
1. Gründe für die Hochstufung der Aktie von Voyager Therapeutics Inc, (ISIN:…
Voyager Therapeutics Tracer Platform Targets CNS Market: Heres Why Im Neutral
…
Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript
…
Voyager Therapeutics, Inc. (VYGR) Q2 2024 Earnings Call Transcript
…
Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript
…
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to…
Voyager Therapeutics gets new chief medical officer
…
Voyageur Therapeutics executes royalty agreement with Rain Cage Carbon
Voyager Therapeutics Inc (NASDAQ:VYGR) announced that it has executed a royalty agreement with its carbon capture and drug development partner…
Voyager Therapeutics, Inc. (VYGR) Q4 2023 Earnings Call Transcript
…